CRISPR Therapeutics AG ($CRSP) Stock Forecast: Down 6.3% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics AG (CRSP) is a biotechnology company specialized in developing gene-based medicines, leveraging CRISPR-Cas9 technology for gene editing.

Why is CRISPR Therapeutics AG going down?

CRSP stock is down 6.3% on Oct 22, 2025 13:42

• Today's downward trend in CRSP stock could be linked to profit-taking by investors following a recent uptick in its price.
• The -2.24% drop might also be influenced by broader market sentiments or shifts within the biotech sector.
• Investor reactions may be tied to potential negative updates or uncertainties surrounding the company's clinical trials, regulatory challenges, or competitive landscape in gene editing.
• It is crucial for investors to stay informed about the company's pipeline progress and regulatory changes to evaluate the future trajectory of CRSP stock.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics AG ( CRSP ) Stock Moves -2.24%: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $72.31, marking a -2.24% move from the previous day.

https://www.zacks.com/stock/news/2773564/crispr-therapeutics-ag-crsp-stock-moves--224-what-you-should-know

Trending Today

Natural Gas ($GAS) Commodity Forecast: Up 7.6% Today

ZCash ($ZEC) Crypto Forecast: Up 6.2% Today

Pepe ($PEPE) Crypto Forecast: Down 5.2% Today

Ethena ($ENA) Crypto Forecast: Down 9.5% Today

Solana ($SOL) Crypto Forecast: Down 5.3% Today

Gasoline ($GASOLINE) Commodity Forecast: Down 4.9% Today

Dogecoin ($DOGE) Crypto Forecast: Down 8.5% Today

XRP ($XRP) Crypto Forecast: Down 7.3% Today

S&P 500 Index ($SPX) Index Forecast: Down 0.4% Today

NASDAQ-100 ($NDX) Index Forecast: Down 0.3% Today

CRISPR Therapeutics AG Price History

10.09.2025 - CRSP Stock was down 5.1%

• CRSP stock saw a significant bearish movement, dropping by 6.98% to close at $67.74.
• The stock's decline was more pronounced than the broader market trend, indicating specific factors impacting CRISPR Therapeutics AG.
• The dip in CRSP stock could be attributed to potential concerns over the company's research and development pipeline or general market volatility affecting biotech stocks.
• Investors may be closely monitoring any updates on CRISPR Therapeutics' clinical trials, regulatory approvals, or competitive landscape to gauge the stock's future performance.

18.08.2025 - CRSP Stock was up 6.2%

• Despite falling more steeply than the broader market in the previous trading session, CRSP closed with a significant bullish movement today.
• The -3.46% move from the previous day might have been a temporary correction or profit-taking by some investors.
• The bullish movement today could be attributed to positive factors like a successful clinical trial, a new partnership, or overall market optimism towards the biotechnology sector.
• Investors in CRSP need to stay updated with the latest developments in the company and the broader biotech industry to make informed decisions.

05.07.2025 - CRSP Stock was down 5.2%

• CRISPR Therapeutics (CRSP) stock closed at $56.26 today, showing a bearish movement of -2.46% from the previous trading day.
• The decline in CRSP stock price is linked to the company's wider second-quarter loss, mainly due to expenses related to the Sirius deal.
• Investors may view the company's emphasis on increasing Casgevy adoption as a risky move amidst current market conditions.
• Market sentiment towards CRSP appears more negative compared to the broader market, reflecting specific concerns about the company's financial performance and strategic choices.

04.07.2025 - CRSP Stock was up 5.7%

• Despite a recent slight decline in trading, CRSP demonstrated strong bullish movement overall.
• Some investors engaged in profit-taking, causing a temporary dip in CRSP's stock price following a period of significant growth.
• The positive momentum in CRSP is likely fueled by advancements in the company's gene-based medicine portfolio, driving up investor confidence.
• While a general market decline had a limited impact on CRSP's stock price, the prevailing positive outlook on the company remains steadfast.

06.09.2025 - CRSP Stock was up 5.0%

• Factors contributing to the rise in CRSP stock today include:
• Despite a recent stock decline, the overall market trend indicates investor optimism towards the future of CRISPR Therapeutics AG.
• The -6.98% change from the previous close could be a temporary adjustment, presenting an opportunity for investors interested in benefiting from the decrease.
• It's important for investors to monitor developments in the CRISPR technology sector closely, as progress or regulatory authorizations could have a significant impact on CRSP stock in the future.

22.09.2025 - CRSP Stock was down 6.3%

• Today's downward trend in CRSP stock could be linked to profit-taking by investors following a recent uptick in its price.
• The -2.24% drop might also be influenced by broader market sentiments or shifts within the biotech sector.
• Investor reactions may be tied to potential negative updates or uncertainties surrounding the company's clinical trials, regulatory challenges, or competitive landscape in gene editing.
• It is crucial for investors to stay informed about the company's pipeline progress and regulatory changes to evaluate the future trajectory of CRSP stock.

29.06.2025 - CRSP Stock was down 7.5%

• Investor caution may be linked to CRISPR Therapeutics' upcoming Q2 earnings report, with focus on Casgevy sales growth and advancements in its gene-editing pipeline.
• The decline in stock value could stem from traders taking profits, particularly following a recent market uptrend, suggesting a short-term adjustment.
• Market dynamics may also be influenced by general market trends or industry-specific developments affecting biotechnology stocks, contributing to the bearish sentiment surrounding CRSP today.

25.06.2025 - CRSP Stock was down 5.2%

• Factors contributing to the downward movement in CRSP stock include:
• Despite the market's upward trajectory, CRSP stock experienced a decline, suggesting investor profit-taking.
• The 3.05% decrease in CRSP's stock price may be linked to overall market instability affecting biotech companies.
• Investors' actions may be influenced by recent developments concerning CRISPR Therapeutics AG, leading to a sell-off of the stock.

16.08.2025 - CRSP Stock was up 5.3%

• Factors contributing to the bullish movement in CRSP stock today include:
• The bullish trend in the market prompting investors to purchase CRSP despite a minor decline in the previous trading session.
• Positive news or advancements in CRSP's gene editing technologies or pipeline boosting investor confidence.
• Strong financial performance and positive future outlook attracting more buyers.
• Possible partnerships or collaborations in the biotech sector involving CRSP piquing investor interest and driving up the stock price.

18.06.2025 - CRSP Stock was up 15.0%

• Key points for the bearish movement in CRSP stock:
• CRSP declining more than the overall market, indicating specific company-related factors at play.
• Investors might have reacted negatively to certain information or developments within the company.
• The -6.54% drop in CRSP's stock price could have triggered profit-taking or stop-loss orders, further exacerbating the decline.
• It is essential for investors to closely monitor any news or updates from CRISPR Therapeutics AG to make informed decisions regarding their investments in the company.

30.08.2025 - CRSP Stock was up 5.7%

• CRISPR Therapeutics AG (CRSP) saw a strong bullish movement today, closing at $61.67, with a +2.24% increase from the previous day.
• This positive momentum could be linked to successful clinical trial outcomes or regulatory clearances related to their gene therapies, fueling optimism among investors regarding the company's future.
• Amidst this upward trend, staying abreast of any potential market fluctuations or regulatory hurdles that may affect CRISPR Therapeutics AG (CRSP) going forward is crucial for investors.

14.09.2025 - CRSP Stock was down 10.4%

• CRSP stock saw a more significant decline compared to the broader market, ending at $68.29, reflecting a -6.54% change from the previous day, indicating a bearish trend.
• The stock's notable drop could be linked to profit-taking activities by investors following a recent price surge or concerns regarding the company's pipeline or financial results.
• Despite the market's positive performance, specific internal factors within CRSP such as regulatory challenges, clinical trial outcomes, or alterations in analyst outlooks might have influenced its stock decline.
• Investors are likely keeping a close watch on developments in the biotech industry and updates on CRISPR technology that could impact CRSP's stock movement in the near future.